Li, M., Xue, Y., Chang, Y., Xu, F., Wu, F., Tian, X., Hu, J., Song, Y., Yu, X., Zhou, F., Zhou, C., Cao, X., Wang, M., Huang, Q. (2026). ELMO2 is a therapeutic vulnerability in mesenchymal-like and drug-resistant non-small cell lung cancer. Nature Communications. https://doi.org/10.1038/s41467-026-72062-y